Upexi Inc
UPXI8.150USD
+0.670+8.96%
Fechamento 07/21, 16:00（ET）Cotações atrasadas em 15 min
11.66MValor de mercado
PerdaP/L TTM
Mais detalhes de Upexi Inc Empresa
Upexi, Inc. is a brand owner specialized in the development, manufacturing and distribution of consumer products. The Company focuses on direct-to-consumer and Amazon brands. The Company’s brands include LuckyTail, PRAX, Cure Mushrooms, Moonwlkr, Gumi Labs, and Upexi Distribution. LuckyTail products consist of its flagship nail grinder and healthy all-natural pet supplements. Gumi Labs manufactures gummies and other products supporting its health and wellness products, including those products manufactured with hemp ingredients. Upexi Distribution manages the warehousing and logistic needs of the Company and provides storage, consolidation, assembly, Amazon preparation, distribution and fulfilment services to its brands and its manufacturing operation.
Informações da empresa
Código da empresaUPXI
Nome da EmpresaUpexi Inc
Data de listagemJun 24, 2021
Fundado em2018
CEO- -
Número de funcionários64
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 24
Endereço3030 Rocky Point Drive
CidadeTAMPA
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal33607
Telefone17013535425
Sitehttps://upexi.com/
Código da empresaUPXI
Data de listagemJun 24, 2021
Fundado em2018
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
884.32K
+484.01%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
365.13K
+194.70%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
159.14K
+941.62%
Mr. Lawrence H. Dugan
Mr. Lawrence H. Dugan
Independent Director
Independent Director
--
--
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
884.32K
+484.01%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
365.13K
+194.70%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
159.14K
+941.62%
Mr. Lawrence H. Dugan
Mr. Lawrence H. Dugan
Independent Director
Independent Director
--
--
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q2
FY2025Q1
FY2024Q1
Por EmpresaUSD
Nome
Receita
Proporção
Internally manufactured
2.51M
62.68%
Contract manufactured
834.86K
20.84%
Purchased as finished goods
659.80K
16.47%
Por RegiãoUSD
Nome
Receita
Proporção
United States of America
3.95M
98.66%
Other
53.69K
1.34%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Internally manufactured
2.51M
62.68%
Contract manufactured
834.86K
20.84%
Purchased as finished goods
659.80K
16.47%
Distribuição de ações
Atualizado em: sex, 18 de jul
Atualizado em: sex, 18 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Attestor Capital LLP
6.79%
GSR Growth Investments LP
4.58%
Novogratz (Michael E)
4.35%
Kathmere Capital Management
4.35%
Marshall (Allan)
1.76%
Other
78.17%
Investidores
Investidores
Proporção
Attestor Capital LLP
6.79%
GSR Growth Investments LP
4.58%
Novogratz (Michael E)
4.35%
Kathmere Capital Management
4.35%
Marshall (Allan)
1.76%
Other
78.17%
Tipos de investidores
Investidores
Proporção
Individual Investor
8.02%
Hedge Fund
6.79%
Corporation
4.58%
Investment Advisor
4.38%
Investment Advisor/Hedge Fund
0.04%
Other
76.19%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
42
6.37M
16.79%
+6.01M
2025Q1
42
311.78K
28.56%
-35.31K
2024Q4
42
307.62K
23.29%
-32.82K
2024Q3
40
303.51K
29.16%
-55.91K
2024Q2
40
319.39K
30.68%
-45.58K
2024Q1
42
328.34K
32.32%
-46.59K
2023Q4
42
319.26K
31.43%
-34.26K
2023Q3
40
369.15K
37.28%
-46.01K
2023Q2
44
368.80K
38.85%
-28.58K
2023Q1
40
400.82K
45.14%
-64.50K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
GSR Growth Investments LP
2.31M
6.08%
+2.31M
--
Apr 24, 2025
Novogratz (Michael E)
2.19M
5.78%
+2.19M
--
Apr 24, 2025
Marshall (Allan)
884.32K
2.33%
+732.89K
+484.01%
Apr 17, 2025
Rudick (Brian Benjamin)
438.60K
1.16%
+438.60K
--
May 23, 2025
Salkind (Gene)
365.13K
0.96%
+241.23K
+194.70%
Apr 17, 2025
Norstrud (Andrew J)
159.14K
0.42%
+143.86K
+941.62%
Apr 17, 2025
BMO Nesbitt Burns Inc.
10.01K
0.03%
--
--
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: dom, 6 de jul
Atualizado em: dom, 6 de jul
Nome
Proporção
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proporção0%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sep 27, 2024
Merger
20<1
Sep 27, 2024
Merger
20<1
Sep 27, 2024
Merger
20<1
Sep 27, 2024
Merger
20<1
Data
Tipo
Proporção
Sep 27, 2024
Merger
20<1
Sep 27, 2024
Merger
20<1
Sep 27, 2024
Merger
20<1
Sep 27, 2024
Merger
20<1
